Colgate-Palmolive (NYSE:CL) Insider Sells $1,978,213.25 in Stock

Colgate-Palmolive Company (NYSE:CL) insider John Hazlin sold 20,989 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This trade represents a 54.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Colgate-Palmolive Trading Up 0.5%

Shares of CL stock opened at $96.61 on Friday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The firm has a market capitalization of $77.87 billion, a PE ratio of 36.87, a price-to-earnings-growth ratio of 4.36 and a beta of 0.29. The stock has a fifty day moving average of $83.80 and a two-hundred day moving average of $81.87. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.91 earnings per share. As a group, research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Key Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Jim Cramer highlighted Colgate’s strong growth on his show, a high-visibility endorsement that can boost investor sentiment and trading interest. Colgate (CL) had great growth, says Jim Cramer
• Positive Sentiment: Zacks Research raised several near‑term and longer‑term EPS estimates (including FY2026, FY2027 and Q4 updates) — a signal of improving analyst expectations that supports the stock’s upside. Market summary with Zacks note: Colgate-Palmolive (CL) — MarketBeat summary
• Positive Sentiment: Recent quarterly results beat estimates (Q4 EPS and revenue topped consensus) and the company recently paid its regular quarterly dividend — both reinforce Colgate’s cash-generation and income-profile that investors prize in staples. Full company/analyst roundup: Colgate-Palmolive (CL) — MarketBeat summary
• Neutral Sentiment: Zacks issued a mix of small raises and cuts across individual quarters (some Q1–Q3 2026/2027 estimates were trimmed while other quarters were nudged higher). The net effect is modest — watch upcoming quarterly cadence rather than reacting to isolated quarter tweaks. Source: MarketBeat/Zacks summary: Colgate-Palmolive (CL) — MarketBeat summary
• Negative Sentiment: Significant insider selling by the COO, Panagiotis Tsourapas — 35,000 shares sold Feb. 11 and another 15,000 on Feb. 12 (disclosures show a large reduction in his holdings). Large exec sales can be perceived negatively by investors even if they’re for diversification or liquidity reasons. Colgate-Palmolive (NYSE:CL) COO Sells $1,467,150.00 in Stock
• Negative Sentiment: Another insider (John Hazlin) recently sold ~20,989 shares; multiple insider sales in a short span increase perceived governance/insider-conviction risk. SEC filing and trade details: SEC Filing — Insider Sales

Institutional Trading of Colgate-Palmolive

Several institutional investors have recently made changes to their positions in the stock. Westside Investment Management Inc. lifted its position in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares in the last quarter. CBIZ Investment Advisory Services LLC increased its stake in shares of Colgate-Palmolive by 86.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after acquiring an additional 150 shares during the last quarter. Triumph Capital Management raised its holdings in shares of Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after acquiring an additional 127 shares in the last quarter. Vermillion & White Wealth Management Group LLC boosted its position in Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after purchasing an additional 155 shares during the last quarter. Finally, Jessup Wealth Management Inc purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $26,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on CL shares. Morgan Stanley lifted their price target on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Jefferies Financial Group lifted their target price on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $94.00 target price on shares of Colgate-Palmolive in a report on Saturday, January 31st. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Finally, Barclays boosted their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 3rd. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus target price of $94.38.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.